Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
By Michael Erman and Deena Beasley Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for ...
Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...
Explore the potential of the HIV drug Maraviroc in slowing glioblastoma growth as discovered by McMaster University ...
Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...
The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...
DE BILT, Netherlands & GLASGOW, Scotland--(BUSINESS WIRE)--Code Pharma today announced positive eight-week results for human immunodeficiency virus (HIV)-drug Gammora®, showing potential to cure HIV ...
HOUSTON, Texas (KTRK) -- The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, ...
Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation ...
The US government paused all foreign assistance in January 2025. This abrupt decision affected the delivery of life-saving HIV medicines and the provision of HIV prevention services to millions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results